APA

Rausch L., Green C., Steinmetz K., LeValley S., Catz P., Zaveri N., Schweikart K., Tomaszewski J. & Mirsalis J. (20110722). Preclinical pharmacokinetic, toxicological and biomarker evaluation of SR16157, a novel dual-acting steroid sulfatase inhibitor and selective estrogen receptor modulator. : Cancer chemotherapy and pharmacology.

Chicago

Rausch Linda, Green Carol, Steinmetz Karen, LeValley Sue, Catz Paul, Zaveri Nurulain, Schweikart Karen, Tomaszewski Joseph and Mirsalis Jon. 20110722. Preclinical pharmacokinetic, toxicological and biomarker evaluation of SR16157, a novel dual-acting steroid sulfatase inhibitor and selective estrogen receptor modulator. : Cancer chemotherapy and pharmacology.

Harvard

Rausch L., Green C., Steinmetz K., LeValley S., Catz P., Zaveri N., Schweikart K., Tomaszewski J. and Mirsalis J. (20110722). Preclinical pharmacokinetic, toxicological and biomarker evaluation of SR16157, a novel dual-acting steroid sulfatase inhibitor and selective estrogen receptor modulator. : Cancer chemotherapy and pharmacology.

MLA

Rausch Linda, Green Carol, Steinmetz Karen, LeValley Sue, Catz Paul, Zaveri Nurulain, Schweikart Karen, Tomaszewski Joseph and Mirsalis Jon. Preclinical pharmacokinetic, toxicological and biomarker evaluation of SR16157, a novel dual-acting steroid sulfatase inhibitor and selective estrogen receptor modulator. : Cancer chemotherapy and pharmacology. 20110722.